HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[A clinical evaluation of clarithromycin in the treatment of pediatric infections]

AbstractClarithromycin (TE-031, A-56268) granules were used to treat various infections in the pediatric field and the results obtained are summarized as follows. 1. TE-031 was administered to a total of 10 patients (5 cases of enteritis, 4 cases of bronchitis and 1 case of tonsillitis). Clinical efficacies were excellent in 6 patients and good in 4 with an efficacy rate of 100%. 2. Neither side effects nor abnormal laboratory test values were observed. There was no rejection of drug disturbing the therapy.
AuthorsS Furukawa, T Okada (Affiliation: Department of Pediatrics, Kagawa Children's Hospital, National Sanatorium.)
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 42 Issue 2 Pg. 420-2 (Feb 1989) ISSN: 0368-2781 [Print] JAPAN
PMID2526255 (Publication Type: Clinical Trial, English Abstract, Journal Article, Multicenter Study)
Chemical References
  • Erythromycin
  • Clarithromycin
Topics
  • Age Factors
  • Bacteria (drug effects, isolation & purification)
  • Bronchitis (drug therapy, microbiology)
  • Child
  • Child, Preschool
  • Clarithromycin
  • Drug Evaluation
  • Drug Resistance, Microbial
  • Enteritis (drug therapy, microbiology)
  • Erythromycin (administration & dosage, analogs & derivatives, pharmacology, therapeutic use)
  • Female
  • Humans
  • Male
  • Multicenter Studies as Topic
  • Tonsillitis (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD